Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening systemShuofeng Yuan, Kwok‐Yung Yuen, Jessica Oi‐Ling Tsang et al.|Pharmacological Research|2020Cited by 71
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variantKun Wen, Kelvin Kai‐Wang To, Jian‐Piao Cai et al.|Frontiers in Cellular and Infection Microbiology|2023Cited by 6